dihexa longecity | c-Met chemical | CAS 1401708-83-5 EllieMD | Dihexa

If a novel agent is available commercially through accelerated approval, some patients may want the guarantee of receiving a novel agent versus having the risk for being randomized to the control arm and never receiving the new therapy

Acute pancreatitis and multiple organ failure-Who beats the odds

The Revelation Pharma manufacturing report pushes this even further

A novel virus-like particle based vaccine platform displaying the placental malaria antigen VAR2CSA

Most people notice an improvement in energy levels within 24-48 hours, though results may vary

toxicity remains rare when clinicians restrict injections to clinically indicated doses and monitor biochemical profiles